Advances in Lung Transplantation - Royal Perth Hospital

More documents

Recommendations

Info

Post-Hoc Analysis of Composite Endpoint: BOS, Death, ReTx, Withdrawal for Lack of Therapeutic Response % Event 100 80 60 40 20 0 p = 0.07 0 0.5 1 1.5 2 2.5 3 Years after Randomization MMF AZA
Randomized, double-blind study of everolimus vs AZA to inhibit the decline of pulmonary function in stable lung & heart-lung transplant recipients - 24 month results - On behalf of the RAD B159 Study Investigators
Page 1 and 2: Advances in Lung Transplantation El
Page 3 and 4: Why is Lung Transplantation so diff
Page 5: Protoplasm Surgical Issues - late r
Page 8 and 9: Donor Availability 1. Impact of Don
Page 10 and 11: Maximizing the Utilization of Donor
Page 15 and 16: Treatment Volume status important -
Page 19 and 20: Improvements in Treatment and Preve
Page 21 and 22: CMV and Lung Transplantation CMV di
Page 23 and 24: Post Transplant CMV Prophylaxis Zam
Page 27 and 28: Long Term Problems Thorn in the sid
Page 29 and 30: The real meaning of BOS… BOS is a
Page 31 and 32: The real meaning of BOS… • BOS
Page 33 and 34: CNI Switch from CyA to Tacrolimus:
Page 35 and 36: hange in FEV1 (% pred) after switch
Page 37 and 38: Azithromycin Panbronchiolitis and C
Page 39 and 40: SURGERY Surgery for gastro- esophag
Page 41 and 42: OB: New Therapies are Needed Ration
Page 43 and 44: Azzola A, Havryk A, Chhajed P, Host
Page 45 and 46: Azzola A, Havryk A, Chhajed P, Host
Page 47: MMF 1.5gm bd 159 patients 40 deaths
Page 51 and 52: Steering Committee of the Australia
Page 53 and 54: Actuarial survival post lung transp
Page 55: RPH First 8 Transplants How have th

Advances in Lung Transplantation - Royal Perth Hospital

Create successful ePaper yourself

Delete template?

Save as template?